Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Update

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 1,747,200 shares, an increase of 151.7% from the July 15th total of 694,202 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Ascentage Pharma Group International Stock Performance

Shares of ASPHF opened at $4.53 on Friday. The business has a 50-day moving average of $4.53 and a 200-day moving average of $6.72. Ascentage Pharma Group International has a 1 year low of $4.53 and a 1 year high of $5.05.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.

Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.